喜炎平联合抗生素治疗慢性阻塞性肺病急性加重的临床效果探讨.docxVIP

喜炎平联合抗生素治疗慢性阻塞性肺病急性加重的临床效果探讨 蒋先芳 (四川消防医院四川成都610073) 【摘要】口的：评估慢性阻塞性肺病急性加重患者采取喜炎平联合抗生素 治疗的临床疗效。方法：将97例慢性阻塞性肺病急性加重患者随机分组。治疗 组49例，采用哌拉西林舒巴坦联合喜炎平治疗。对照组48例，单用哌拉西林舒 巴坦治疗。结果：治疗组总有效率95.91%,对照组总有效率66.67%,两组疗效 有显著性差异(PV0.05)。治疗组治疗住院时间缩短(t=6.1, P0.01)o结论： 喜炎平具有抗病毒、抗菌、清热解毒等多重作用，慢性阻塞性肺病急性加重患者 予喜炎平联合抗生素治疗效果显著；值得采纳应用。 【关键词】恵炎平；抗生素；慢性阻塞性肺病急性加重 【中图分类号】R563 【文献标识码】A 【文章编号】2095-1752 (2016) 08-0026-02 Xi phlogistic flat with antibiotic treatment the clinical effect of acute exacerbatio n of chr onic obstructive pulm on ary disease (copd) Jiang Xianfang. Sichuan Fire Hospital, Sichuan Provinee, Chengdu 61OO73.China [Abstract lObjective Evaluati on of chr on ic obstructive pulm on ary disease (copd) patients with acute aggravating take xi phlogistic flat with antibiotic therapy clinical curative effect. Methods The 97 cases of chronic obstructive pulm on ary disease (copd) patients with acute exacerbation of random grouping. Treatment group (49 cases, the use of pp raschig Lin Shu ba jotham united xi phlogistic treatment. The control group, 48 cases to use pp raschig Lin Shu treatment. Results Treatment group total effectiveness 95.91%, control group total effective rate 66.67%, the curative effect of the two groups have significant differenee (P lt; 0.05). Treatment group hospitalization time (t = 6.1, P lt; O.O1J.Conclusion Xi phlogistic flat has multiple fun ctio n to an tiviral, an tibacterial, qin grejiedu, chr onic obstructive pulm on ary disease (copd) patients with acute aggravating to xi phlogistic flat with antibiotic therapy effect is obvious; Worth adopted application. 【Key words］ Xi phlogistic flat; Antibiotics; Acute exacerbation of chronic obstructive lung disease 喜炎平注射液是从穿心莲全叶中提取出的穿心莲乙素，经过独特的磺化专利 工艺制成的水溶性注射剂，具有抗病毒、抗菌、快速退热、强劲消炎等广泛的药 理作用。慢性阻塞性肺疾病(chronic obstructive pulmona—ry disease, COPD)是一* 种可以预防、可以治疗的疾病，以持续气流受限为特征，气流受限不完全可逆, 并呈进行性发展，与气道和肺组织对香烟、烟雾等有害气体或有害颗粒的异常慢 性炎症反应有关，COPD主要累及肺脏，也可引起全身不良效应，并与患者的疾 病严重程度相关。目前慢性阻塞性肺疾病急性加重(AECOPD),治疗仍以抗细菌 药物为主，但长期反复应用抗生素易造成菌群失调及细菌耐药。故寻找种中